Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

Rudolf Foundation Clinic

Status: Unknown

Conditions: Age-Related Macular Degeneration

Treatments: Other: cd 35, cd21, cd55

Study type: Observational

Funder types: Other

Identifiers

NCT01174407

EK08010-VK

Details and patient eligibility

About

The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group.

Enrollment: 120 estimated patients

Sex: All

Ages: 55+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Man and women over 18 years old
• Filled out informed consent
• Diagnosis of non-exudative/ exudative age related macular degeneneration

Exclusion criteria

• Inherited retinal diseases
• Other acquired retinal/ macular
• Missing informed consent

Trial design

120 participants in 1 patient group

cd35

Treatment:

Other: cd 35, cd21, cd55